Shorla Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHORLA, and what generic alternatives to SHORLA drugs are available?
SHORLA has three approved drugs.
There are three US patents protecting SHORLA drugs.
There are twenty patent family members on SHORLA drugs in eighteen countries and five supplementary protection certificates in five countries.
Summary for Shorla
| International Patents: | 20 |
| US Patents: | 3 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Shorla
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shorla | NELARABINE | nelarabine | INJECTABLE;INTRAVENOUS | 214809-001 | Mar 3, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Shorla | JYLAMVO | methotrexate | SOLUTION;ORAL | 212479-001 | Nov 29, 2022 | RX | Yes | Yes | 11,771,701 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Shorla | JYLAMVO | methotrexate | SOLUTION;ORAL | 212479-001 | Nov 29, 2022 | RX | Yes | Yes | 11,129,833 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Shorla | TEPYLUTE | thiotepa | SOLUTION;INTRAVENOUS | 216984-001 | Jun 25, 2024 | RX | Yes | Yes | 11,975,013 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Shorla Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1243638 | ⤷ Subscribe |
| China | 107106485 | ⤷ Subscribe |
| Lithuania | 3212237 | ⤷ Subscribe |
| United Kingdom | 2531940 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 2016067024 | ⤷ Subscribe |
| Japan | 2017533274 | ⤷ Subscribe |
| China | 116747190 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Shorla Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0294114 | C300302 | Netherlands | ⤷ Subscribe | PRODUCT NAME: NELARABINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR BAAR ZOUT, ETHER OF ESTER; REGISTRATION NO/DATE: EU/1/07/403/001 20070822 |
| 0294114 | 55/2007 | Austria | ⤷ Subscribe | PRODUCT NAME: NELARABINE; REGISTRATION NO/DATE: EU/1/07/403/001 20070822 |
| 0294114 | 07C0058 | France | ⤷ Subscribe | PRODUCT NAME: NELARABINE, OU L?UN DE SES DERIVES PHYSIOLOGIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/07/403/001 DU 20070822; REGISTRATION NO/DATE AT EEC: EU/1/07/403/001 DU 20070822 |
| 0294114 | 2007C/063 | Belgium | ⤷ Subscribe | PRODUCT NAME: NELARABINE; REGISTRATION NO/DATE: EU/1/07/403/001 20070823 |
| 0294114 | SPC/GB08/006 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: NELARABINE, OR ANY PHARMACEUTICALLY ACCEPTABLE SALTS, ETHERS, ESTERS, OR SALTS OF SUCH ESTERS THEREOF.; REGISTERED: UK EU/1/07/403/001 20070822 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
